Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 2

Expert review on coronary calcium

Authors Matthew J Budoff, Khawar M Gul

Published Date May 2008 Volume 2008:4(2) Pages 315—324

DOI http://dx.doi.org/10.2147/VHRM.S1160

Published 5 May 2008

Matthew J Budoff, Khawar M Gul

Division of Cardiology, Saint John’s Cardiovascular Research Center, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California, USA

Abstract: While there is no doubt that high risk patients (those with >20% ten year risk of future cardiovascular event) need more aggressive preventive therapy, a majority of cardiovascular events occur in individuals at intermediate risk (10%–20% ten year risk). Accurate risk assessment may be helpful in decreasing cardiovascular events through more appropriate targeting of preventive measures. It has been suggested that traditional risk assessment may be refined with the selective use of coronary artery calcium (CAC) or other methods of subclinical atherosclerosis measurement. Coronary calcification is a marker of atherosclerosis that can be quantified with the use of cardiac CT and it is proportional to the extent and severity of atherosclerotic disease. The published studies demonstrate a high sensitivity of CAC for the presence of coronary artery disease but a lower specificity for obstructive CAD depending on the magnitude of the CAC. Several large clinical trials found clear, incremental predictive value of CAC over the Framingham risk score when used in asymptomatic patients. Based on multiple observational studies, patients with increased plaque burdens (increased CAC) are approximately ten times more likely to suffer a cardiac event over the next 3–5 years. Coronary calcium scores have outperformed conventional risk factors, highly sensitive C-reactive protein (CRP) and carotid intima media thickness (IMT) as a predictor of cardiovascular events. The relevant prognostic information obtained may be useful to initiate or intensify appropriate treatment strategies to slow the progression of atherosclerotic vascular disease. Current data suggests intermediate risk patients may benefit most from further risk stratification with cardiac CT, as CAC testing is effective at identifying increased risk and in motivating effective behavioral changes. This article reviews information pertaining to the clinical use of CAC for assessing coronary atherosclerosis as a useful predictor of coronary artery disease (CAD) in certain population of patients.

Keywords: computed tomography, electron beam, prognosis, review, coronary artery calcification, calcium score, atherosclerosis, multi-detector computed tomography

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ

Vascular Health and Risk Management 2011, 7:719-724

Published Date: 2 December 2011

Readers of this article also read:

Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis

Zhang YT, Shen LN, Zhao JH, Feng NP

International Journal of Nanomedicine 2014, 9:669-678

Published Date: 23 January 2014

Electrospun fiber membranes enable proliferation of genetically modified cells

Borjigin M, Eskridge C, Niamat R, Strouse B, Bialk P, Kmiec EB

International Journal of Nanomedicine 2013, 8:855-864

Published Date: 27 February 2013

Nanomedicine as an emerging approach against intracellular pathogens

Armstead AL, Li B

International Journal of Nanomedicine 2011, 6:3281-3293

Published Date: 9 December 2011

Erratum

Iancu C, Mocan L

International Journal of Nanomedicine 2011, 6:2543-2544

Published Date: 21 October 2011

Role of the transient receptor potential vanilloid 1 in inflammation and sepsis

Devesa I, Planells-Cases R, Fernández-Ballester GJ, González-Ros JM, Ferrer-Montiel AV, Fernández-Carvajal AM

Journal of Inflammation Research 2011, 4:67-81

Published Date: 24 May 2011

Difluprednate ophthalmic emulsion 0.05% (Durezol®) administered two times daily for managing ocular inflammation and pain following cataract surgery

Stephen Smith, Douglas Lorenz, James Peace, et al.

Clinical Ophthalmology 2010, 4:983-991

Published Date: 30 August 2010